10.02.2014 14:00:00
|
Smiths Medical Launches MR Conditional Wire-reinforced Silicone Tracheostomy Tubes for Neonates and Pediatric Patients
Smiths Medical, a leading global medical device manufacturer, announced today that its Portex Bivona FlexTend™ TTS™ tracheostomy tubes will now be included in the company’s standard product offering. The Bivona Flextend™ TTS™ neonatal and pediatric tubes feature a proximal shaft extension helping to keep connections away from the neck, chin, and stoma, intended to enhance patient comfort which could prevent pressure ulcers. The Bivona FlexTend™ TTS™ tracheostomy tubes were originally only available as customized products, manufactured in response to clinicians’ orders.
(Photo: Business Wire)
Bivona FlexTend™ TTS™ tracheostomy tubes, made of soft, natural, biocompatible silicone, are intended to be gentle on the sensitive tissues of neonatal and pediatric patients who require intermittent or temporary cuff use. An inflatable cuff integrated into the outer wall of the tube’s shaft can be filled with sterile water to secure the tube in the patient’s trachea and creates a seal between the tube and trachea to direct incoming and outgoing breaths through the inner lumen. Directing all airflow through the lumen helps to optimize respiration for ventilated patients and for patients who perform lung expanding breathing therapies. When a seal is no longer needed, the cuff can be deflated and it will rest tight-to-shaft (TTS), reducing the risk of trauma to the trachea and allowing airflow around the tube supporting the ability to speak.
"We are pleased to add this specialty device to our standard Bivona® tracheostomy product portfolio,” said Tommy Johns, Vice President Global Product Management. "Providing greater accessibility to the Bivona FlexTend™ TTS™ tracheostomy tubes ensures that patients and care providers can have exactly what they need, precisely when they need it.”
The new Bivona FlexTend™ TTS™ tracheostomy tubes, as standard product, are manufactured in volume and stocked to fill orders promptly and to enable customers to keep inventory on hand for eventual needs. Smiths Medical will continue to provide Bivona FlexTend™ TTS™ tracheostomy tubes through its customization service. Customized tubes assembled to follow the unique contours and dimensions of a patient’s neck and trachea are essential to patients who have unique needs or an atypical tracheal anatomy.
Bivona FlexTend™ TTS™ tracheostomy tubes are now available in the United States and will be available in other markets later this year.
About Smiths Medical
Smiths Medical www.smiths-medical.com is a leading supplier of specialized medical devices and equipment for global markets, focusing on the medication delivery, vital care and safety devices market segments. It is part of Smiths Group www.smiths.com, a global leader in applying advanced technologies for markets in threat and contraband detection, energy, medical devices, communications and engineered components. Smiths Group employs around 23,000 people in more than 50 countries.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140210005029/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Smiths PLCmehr Nachrichten
18.11.24 |
FTSE 100-Wert Smiths-Aktie: So viel Gewinn hätte ein Smiths-Investment von vor 10 Jahren eingefahren (finanzen.at) | |
14.11.24 |
FTSE 100-Papier Smiths-Aktie: Mit dieser Dividende bereitet Smiths Anlegern eine Freude (finanzen.at) | |
13.11.24 |
FTSE 100-Handel aktuell: FTSE 100 schlussendlich mit grünen Vorzeichen (finanzen.at) | |
13.11.24 |
Verluste in London: FTSE 100 verbucht am Nachmittag Verluste (finanzen.at) | |
13.11.24 |
Handel in London: Pluszeichen im FTSE 100 (finanzen.at) | |
13.11.24 |
FTSE 100-Handel aktuell: FTSE 100 bewegt sich zum Handelsstart im Plus (finanzen.at) | |
12.11.24 |
Dienstagshandel in London: FTSE 100 schlussendlich schwächer (finanzen.at) | |
12.11.24 |
Börse London: FTSE 100 verliert am Dienstagnachmittag (finanzen.at) |